SANA · Sana Biotechnology Inc
United States · RS rating 17 · As of 2026-11-03
| Price | 2.44 USD |
|---|---|
| 1-day change | +1.7% |
| RS rating (overall / 1M / 3M / 12M) | 17 / 27 / 20 / 21 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 9 / 21 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -31.2% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +52.9% |
| Market cap (USD) | $918.0M |